✦ LIBER ✦

Altered metabolism in head and neck squamous cell carcinoma: an opportunity for identification of novel biomarkers and drug targets

✍ Scribed by Vlad C. Sandulache; Jeffrey N. Myers

Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 238 KB
Volume: 34
Category: Article
ISSN: 1043-3074
DOI: 10.1002/hed.21664

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Tumor cells were first shown to exhibit a distinct metabolic phenotype over 80 years ago. Since then, it has become clear that multiple oncogenic events contribute to the development of a metabolic phenotype that supports rapid proliferation. Because this phenotype represents an essential component of tumorigenesis and disease progression, it also represents a potential source of biomarkers associated with aggressive disease. In addition, the addiction of tumor cells to specific nutrients and the up‐regulation of key metabolic enzymes provide unique opportunities for pharmacologic manipulation. Despite the use of multimodality treatment, survival rates for patients with advanced head and neck squamous cell carcinoma (HNSCC) remain low, partially attributed to the development of drug resistance. In this review, we evaluate the role of altered HNSCC metabolism as both a source of novel biomarkers and a means to bypass resistance mechanisms to conventional forms of therapy. © 2011 Wiley Periodicals, Inc. Head Neck, 2012

📜 SIMILAR VOLUMES

Evaluation of drug transporters' signifi

Evaluation of drug transporters' significance for multidrug resistance in head and neck squamous cell carcinoma

✍ Dirk Theile; Nahal Ketabi-Kiyanvash; Christel Herold-Mende; Gerhardt Dyckhoff; T 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 462 KB 👁 2 views

## Abstract ## Background. Multidrug resistance (MDR) hampers chemotherapy in head and neck squamous cell carcinoma (HNSCC). There is little information about MDR mediating drug transporters in HNSCC. ## Methods. Nine HNSCC cell lines were characterized concerning drug transporter expression and

Examining expression of folate receptor

Examining expression of folate receptor in squamous cell carcinoma of the head and neck as a target for a novel nanotherapeutic drug

✍ Nabil F. Saba; Xu Wang; Susan Müller; Mourad Tighiouart; Kwangjae Cho; Shuming N 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 359 KB 👁 1 views

## Abstract ## Background Nanotechnology‐based drug delivery approaches may help increase therapeutic efficacy and decrease side effects of chemotherapeutics. We investigated expression levels of folate receptor in squamous cell carcinoma of the head and neck (SCCHN) to evaluate folate receptor as

Identification of a novel therapeutic ta

Identification of a novel therapeutic target for head and neck squamous cell carcinomas: A role for the neurotensin-neurotensin receptor 1 oncogenic signaling pathway

✍ Satoya Shimizu; Jun Tsukada; Takashi Sugimoto; Naoko Kikkawa; Keita Sasaki; Hide 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 French ⚖ 321 KB 👁 1 views

## Abstract Distant metastasis is a major factor associated with poor prognosis in head and neck squamous cell carcinomas (HNSCC), but little is known of its molecular mechanisms. New markers that predict clinical outcome, in particular the ability of primary tumors to develop metastatic tumors, ar

Biodegradable polymer–mediated intratumo

Biodegradable polymer–mediated intratumoral delivery of cisplatin for treatment of human head and neck squamous cell carcinoma in a chimeric mouse model

✍ Fang-An Chen; M. Abraham Kuriakose; Ming-Xing Zhou; Mark D. DeLacure; Richard L. 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 187 KB 👁 2 views

## Abstract ## Background. The effectiveness of chemotherapeutic agents is proportional to the dose of the agents at their targets; however, the dose is limited by systemic toxicity. Attempts have been made to improve therapeutic effectiveness by increasing maximum tolerated dose (MTD) of chemothe